Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
T3 Supplementation in Depression
NCT00158990Phase 3Completed
- Sponsor
- Hadassah Medical Organization
- Start
- Oct 2002
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of liothyronine in major depressive disorder (MDD), bipolar disorder (BD), sponsored by Hadassah Medical Organization. Started Oct 2002; status: completed.
02
Drugs
liothyronine
03
Conditions
major depressive disorder (MDD)bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00158990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00158990.